15.26
price up icon3.60%   0.53
after-market 시간 외 거래: 15.62 0.36 +2.36%
loading

Uniqure N V 주식(QURE)의 최신 뉴스

pulisher
08:02 AM

QURE ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of “Distorted” Data - GlobeNewswire Inc.

08:02 AM
pulisher
05:40 AM

Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline - PR Newswire

05:40 AM
pulisher
04:19 AM

uniQure N.V. Stockholders Should Contact Robbins LLP for Information About Leading the QURE Class Ac - PharmiWeb.com

04:19 AM
pulisher
03:32 AM

UNIQURE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. ... - Bluefield Daily Telegraph

03:32 AM
pulisher
03:31 AM

UNIQURE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. Stockholders with Large Losses to Contact the Firm - Carroll County Mirror-Democrat

03:31 AM
pulisher
01:17 AM

uniQure N.V. Stockholders Should Contact Robbins LLP for Information About Leading the QURE Class Action - Bluefield Daily Telegraph

01:17 AM
pulisher
10:00 AM

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming DeadlinesQURE - PR Newswire

10:00 AM
pulisher
08:11 AM

UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of ... - Bluefield Daily Telegraph

08:11 AM
pulisher
08:11 AM

UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard - GlobeNewswire

08:11 AM
pulisher
Mar 18, 2026

uniQure Shareholder Alert: ClaimsFiler Reminds Investors - GlobeNewswire

Mar 18, 2026
pulisher
Mar 18, 2026

Uniqure NV (QURE) - MSN

Mar 18, 2026
pulisher
Mar 18, 2026

QURE ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data - PR Newswire

Mar 18, 2026
pulisher
Mar 18, 2026

QURE stock crashes 32% in a week: Here's what you should know - MSN

Mar 18, 2026
pulisher
Mar 18, 2026

A Huntington’s researcher on the UniQure-FDA fray - statnews.com

Mar 18, 2026
pulisher
Mar 18, 2026

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure LawsuitQURE - PR Newswire

Mar 18, 2026
pulisher
Mar 18, 2026

UniQure NV (NASDAQ:QURE) Q4 2025 earnings call transcript - MSN

Mar 18, 2026
pulisher
Mar 18, 2026

QURE Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in uniQure N.V. Securities Lawsuit -- The Gross Law Firm - Lelezard

Mar 18, 2026
pulisher
Mar 17, 2026

QURE ALERT: FDA Reportedly Accuses uniQure of Pushing - GlobeNewswire

Mar 17, 2026
pulisher
Mar 17, 2026

QURE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 - PR Newswire

Mar 17, 2026
pulisher
Mar 17, 2026

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before ... - Bluefield Daily Telegraph

Mar 17, 2026
pulisher
Mar 17, 2026

Holzer & Holzer, LLC Reminds Investors of April 13, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Kyndryl Holdings, Inc. (KD) and uniQure N.V. (QURE) - lincolnjournal.com

Mar 17, 2026
pulisher
Mar 17, 2026

uniQure (NASDAQ:QURE) Shares Gap DownShould You Sell? - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire

Mar 17, 2026
pulisher
Mar 16, 2026

Class Action Filed Against uniQure N.V. (QURE) Seeking Recovery for Investors – Contact Levi & Korsinsky - GlobeNewswire

Mar 16, 2026
pulisher
Mar 16, 2026

QURE INVESTOR ALERT: uniQure Faces Securities Class Action Over AMT-130 Clinical Trial DesignHagens Berman - PR Newswire

Mar 16, 2026
pulisher
Mar 16, 2026

uniQure N.V. (NASDAQ:QURE) Sees Significant Growth in Short Interest - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Portnoy Law Firm Announces Class Action on Behalf of uniQure N.V. Investors - GlobeNewswire

Mar 16, 2026
pulisher
Mar 16, 2026

Fred Alger Management LLC Acquires New Position in uniQure N.V. $QURE - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Darwin Global Management Ltd. Purchases New Shares in uniQure N.V. $QURE - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit - GuruFocus

Mar 16, 2026
pulisher
Mar 15, 2026

uniQure N.V. $QURE is Boxer Capital Management LLC's 2nd Largest Position - MarketBeat

Mar 15, 2026
pulisher
Mar 15, 2026

Boone Capital Management LLC Makes New Investment in uniQure N.V. $QURE - MarketBeat

Mar 15, 2026
pulisher
Mar 15, 2026

uniQure N.V. Stock (ISIN: IL0011559904) Faces Pressure Amid Gene Therapy Setbacks - AD HOC NEWS

Mar 15, 2026
pulisher
Mar 14, 2026

uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP: Investors Face April 13, 2026, Deadline - NewMediaWire

Mar 14, 2026
pulisher
Mar 14, 2026

FinancialContentuniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP: Investors Face April 13, 2026, Deadline - FinancialContent

Mar 14, 2026
pulisher
Mar 14, 2026

Quinn Opportunity Partners LLC Acquires New Stake in uniQure N.V. $QURE - MarketBeat

Mar 14, 2026
pulisher
Mar 14, 2026

uniQure N.V. $QURE Position Decreased by Integral Health Asset Management LLC - MarketBeat

Mar 14, 2026
pulisher
Mar 14, 2026

Avoro Capital Advisors LLC Has $259.42 Million Position in uniQure N.V. $QURE - MarketBeat

Mar 14, 2026
pulisher
Mar 14, 2026

QURE INVESTOR ALERT: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of uniQure N.V. Investors - ACCESS Newswire

Mar 14, 2026
pulisher
Mar 13, 2026

uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - PR Newswire

Mar 13, 2026
pulisher
Mar 13, 2026

QURE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Mar 13, 2026
pulisher
Mar 13, 2026

uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz - GuruFocus

Mar 13, 2026
pulisher
Mar 13, 2026

UniQure to rally around 92%? Here are 10 top analyst forecasts for Wednesday - MSN

Mar 13, 2026
pulisher
Mar 13, 2026

QUREuniQure N.V Stock Price and Quote - Finviz

Mar 13, 2026
pulisher
Mar 13, 2026

uniQure N.V.Ordinary Shares (NQ: QURE - The Chronicle-Journal

Mar 13, 2026
pulisher
Mar 13, 2026

uniQure (NASDAQ:QURE) Trading Down 8.3%Here's Why - MarketBeat

Mar 13, 2026
pulisher
Mar 13, 2026

Why (QURE) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Mar 13, 2026
pulisher
Mar 13, 2026

QURE jumps 20% – analysts upgrade stock on Huntington’s disease therapy update, retail eyes $150 - MSN

Mar 13, 2026
pulisher
Mar 13, 2026

QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire

Mar 13, 2026
pulisher
Mar 13, 2026

QURE Shareholder Alert: April 13, 2026 Lead Plaintiff Deadline in uniQure N.V. Securities Class ... - Bluefield Daily Telegraph

Mar 13, 2026
pulisher
Mar 13, 2026

QURE Shareholder Alert: April 13, 2026 Lead Plaintiff - GlobeNewswire

Mar 13, 2026
pulisher
Mar 13, 2026

Rosalind Advisors Inc. Acquires New Shares in uniQure N.V. $QURE - MarketBeat

Mar 13, 2026
pulisher
Mar 13, 2026

UniQure Faces AMT-130 Scrutiny As FDA Shifts And Lawsuits Weigh - Sahm

Mar 13, 2026
pulisher
Mar 13, 2026

uniQure (QURE) Upgraded to Outperform by Mizuho, Price Target Ra - GuruFocus

Mar 13, 2026
pulisher
Mar 12, 2026

uniQure upgraded at Mizuho on improved outlook for Huntington's asset AMT-130 - Seeking Alpha

Mar 12, 2026
pulisher
Mar 12, 2026

User - The Chronicle-Journal

Mar 12, 2026
pulisher
Mar 12, 2026

QURE ALERT: FDA Reportedly Accuses uniQure of Pushing "Distorted" and "Manipulated" Data For "Failed" AMT-130 Drug Amid Pending Securities Class ActionHagens Berman - Morningstar

Mar 12, 2026
pulisher
Mar 12, 2026

A Unique Situation For UniQure (QURE) - Seeking Alpha

Mar 12, 2026
pulisher
Mar 12, 2026

Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire

Mar 12, 2026
pulisher
Mar 12, 2026

QURE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Mar 12, 2026
pulisher
Mar 12, 2026

HC Wainwright Has Negative Forecast for uniQure Q1 Earnings - MarketBeat

Mar 12, 2026
pulisher
Mar 12, 2026

Mizuho upgrades UniQure NV (QURE) - MSN

Mar 12, 2026
pulisher
Mar 12, 2026

Atika Capital Management LLC Invests $5.25 Million in uniQure N.V. $QURE - MarketBeat

Mar 12, 2026
pulisher
Mar 11, 2026

Lawsuit filed for Investors who lost money with shares of uniQure N.V. (NASDAQ: QURE) - openPR.com

Mar 11, 2026
pulisher
Mar 11, 2026

uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V.QURE - GlobeNewswire

Mar 11, 2026
$99.29
price up icon 1.20%
$27.80
price up icon 0.00%
$52.37
price down icon 0.06%
$89.31
price down icon 0.77%
$144.00
price up icon 0.91%
biotechnology ONC
$282.72
price up icon 0.15%
자본화:     |  볼륨(24시간):